INIS
patients
100%
arthritis
77%
diseases
43%
levels
37%
biological markers
37%
concentration
32%
genes
27%
comparative evaluations
27%
bones
25%
inflammation
20%
data
19%
control
19%
tumors
19%
insulin
18%
diabetes mellitus
17%
interferon
17%
humans
17%
risks
17%
sensitivity
17%
therapy
17%
reviews
16%
women
15%
values
14%
proteins
14%
nmr imaging
14%
peptides
14%
oxidation
13%
cancer
12%
evaluation
12%
phenotype
11%
brain
11%
bone marrow
10%
interleukins
10%
vitamin c
10%
medicine
10%
antibodies
9%
blood
9%
power
8%
fibrosis
8%
metastases
8%
assessments
8%
aging
8%
drugs
7%
in vivo
7%
pathogenesis
7%
men
7%
methotrexate
7%
populations
7%
cytokines
7%
plasma
7%
Medicine and Dentistry
Rheumatoid Arthritis
41%
Biological Marker
13%
Disease
12%
Cardiac Magnetic Resonance Imaging
10%
Gene Expression
9%
Systematic Review
9%
Musculoskeletal Disease
7%
Rheumatic Disease
7%
Chromogranin A
7%
Neuroendocrine Tumor
7%
T Cell Subset
7%
Stromal Cell
7%
Maturity Onset Diabetes of the Young
7%
Patient with Type 2 Diabetes
7%
TNF Inhibitor
7%
Interleukin 7
7%
Interferon
7%
T Cell
7%
Fibrosis
6%
Cardiovascular Risk
5%
Diagnosis
5%
Interferon Type I
5%
Cytokine
5%
Keyphrases
Rheumatoid Arthritis
26%
Type 2 Diabetic Patients
14%
Neuroendocrine Tumor
10%
Chromogranin A
10%
Vitamin C
10%
Osteocalcin
10%
Type 2 Diabetes Mellitus (T2DM)
8%
Biochemical Parameters
8%
Bone Turnover
8%
Interleukin-7 (IL-7)
7%
Early Rheumatoid Arthritis
7%
Human Mesenchymal Stem Cells (hMSCs)
7%
Diagnostic Power
7%
Mesenchymal Stromal Cells
7%
Arsenic Trioxide
7%
Rheumatoid Arthritis Patients
6%
Gene Expression
5%
Vitamin D
5%
Traditional Cardiovascular Risk Factors
5%
Cancer Cells
5%
Oxidative Stress
5%